Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse

被引:51
作者
Abiru, N [1 ]
Wegmann, D [1 ]
Kawasaki, E [1 ]
Gottlieb, P [1 ]
Simone, E [1 ]
Eisenbarth, GS [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
关键词
autoimmunity; I-A(g7); insulin peptide; NOD mice; T-cell epitope;
D O I
10.1006/jaut.2000.0369
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells isolated from islets of non-obese diabetic (NOD) mice are enriched for insulin-reactive cells. The great majority of these T cells recognize insulin B chain peptide (B:9-23). B:9-23 reactive T cell clones are diabetogenic and show a dramatic TCR alpha-chain restriction (predominant AV13S3). We have studied the reactivity of five different B:9-23 reactive T cell clones to truncated peptides and alanine substituted analogues of B:9-23. Amongst these AV13S3 T cell clones, one reacted with peptide B:9-16 and four with B:13-23. The two peptides have in common only four amino acids (B:13-16; EALY). Having defined minimal peptide epitopes, we evaluated a mutant insulin sequence (B:13 glutamine) which retains metabolic activity. As predicted, this single amino acid change abrogated T cell reactivity. In addition, we have created a modified I-A(g7) gene with the B:9-23 peptide covalently linked to I-A(g7). Antigen presenting cells transfected with this construct were excellent presenting cells for all clones studied. The definition of dual peptide motifs and creation of bioactive covalent I-A(g7)-B:9-23 should facilitate studies of the pathogenic significance and antigen recognition by B:9-23 reactive diabetogenic T cells. (C) 2000 Academic Press.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 30 条
[1]   INSULIN-DEPENDENT DIABETES-MELLITUS AS A BETA-CELL TARGETED DISEASE OF IMMUNOREGULATION [J].
BACH, JF .
JOURNAL OF AUTOIMMUNITY, 1995, 8 (04) :439-463
[2]   PREVENTION OF DIABETES IN THE NOD MOUSE - IMPLICATIONS FOR THERAPEUTIC INTERVENTION IN HUMAN-DISEASE [J].
BOWMAN, MA ;
LEITER, EH ;
ATKINSON, MA .
IMMUNOLOGY TODAY, 1994, 15 (03) :115-120
[3]   MONOMERIC INSULINS AND THEIR EXPERIMENTAL AND CLINICAL IMPLICATIONS [J].
BRANGE, J ;
OWENS, DR ;
KANG, S ;
VOLUND, A .
DIABETES CARE, 1990, 13 (09) :923-954
[4]   ISLET-SPECIFIC T-CELL CLONES FROM NONOBESE DIABETIC MICE EXPRESS HETEROGENEOUS T-CELL RECEPTORS [J].
CANDEIAS, S ;
KATZ, J ;
BENOIST, C ;
MATHIS, D ;
HASKINS, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6167-6170
[5]  
CarrascoMarin E, 1996, J IMMUNOL, V156, P450
[6]   CHARACTERIZATION OF INSULIN AUTOANTIBODIES IN RELATIVES OF PATIENTS WITH TYPE-I DIABETES [J].
CASTANO, L ;
ZIEGLER, AG ;
ZIEGLER, R ;
SHOELSON, S ;
EISENBARTH, GS .
DIABETES, 1993, 42 (08) :1202-1209
[7]  
DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430
[8]   Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23) [J].
Daniel, D ;
Wegmann, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :956-960
[9]   SUPERANTIGENS INTERACT WITH MHC CLASS-II MOLECULES OUTSIDE OF THE ANTIGEN GROOVE [J].
DELLABONA, P ;
PECCOUD, J ;
KAPPLER, J ;
MARRACK, P ;
BENOIST, C ;
MATHIS, D .
CELL, 1990, 62 (06) :1115-1121
[10]   Phenotypic alterations in insulin-deficient mutant mice [J].
Duvillie, B ;
Cordonnier, N ;
Deltour, L ;
DandoyDron, F ;
Itier, JM ;
Monthioux, E ;
Jami, J ;
Joshi, RL ;
Bucchini, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5137-5140